Novartis Stock Options Expiring on 21st of March
| NVS Stock | USD 97.53 0.33 0.34% |
Novartis' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 0.47. The Novartis option chain provides detailed quote and price information for the current Novartis AG ADR option contracts. It shows all of Novartis' listed puts, calls, expiration dates, strike prices, and other pricing information.
Novartis Current Options Market Mood
Novartis' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Novartis Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of Novartis' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Novartis' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Novartis contract
Base on the Rule 16, the options market is currently suggesting that Novartis AG ADR will have an average daily up or down price movement of about 0.0294% per day over the life of the 2025-03-21 option contract. With Novartis trading at USD 97.53, that is roughly USD 0.0286. If you think that the market is fully incorporating Novartis' daily price movement you should consider buying Novartis AG ADR options at the current volatility level of 0.47%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Novartis |
Novartis Option Chain
When Novartis' strike price is surpassing the current stock price, the option contract against Novartis AG ADR stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Novartis' option chain is a display of a range of information that helps investors for ways to trade options on Novartis. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Novartis. It also shows strike prices and maturity days for a Novartis against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | NVS250321C00100000 | 4 | 100.0 | 1.55 - 3.5 | 2.47 | Out |
Call | NVS250321C00105000 | 1 | 105.0 | 0.0 - 2.4 | 1.0 | Out |
Call | NVS250321C00110000 | 0 | 110.0 | 0.0 - 2.35 | 2.35 | |
Call | NVS250321C00115000 | 0 | 115.0 | 0.0 - 2.15 | 2.15 | |
Call | NVS250321C00120000 | 0 | 120.0 | 0.0 - 1.45 | 1.45 | |
Call | NVS250321C00125000 | 0 | 125.0 | 0.0 - 2.05 | 2.05 | |
Call | NVS250321C00130000 | 0 | 130.0 | 0.0 - 2.05 | 2.05 | |
Call | NVS250321C00135000 | 0 | 135.0 | 0.0 - 2.05 | 2.05 | |
Call | NVS250321C00140000 | 0 | 140.0 | 0.0 - 2.15 | 2.15 | |
Call | NVS250321C00145000 | 0 | 145.0 | 0.0 - 2.15 | 2.15 | |
Put | NVS250321P00100000 | 0 | 100.0 | 4.2 - 8.5 | 4.2 | In |
Put | NVS250321P00105000 | 0 | 105.0 | 8.2 - 12.2 | 8.2 | In |
Put | NVS250321P00110000 | 0 | 110.0 | 12.8 - 16.7 | 12.8 | In |
Put | NVS250321P00115000 | 0 | 115.0 | 17.7 - 21.6 | 17.7 | In |
Put | NVS250321P00120000 | 0 | 120.0 | 22.2 - 26.5 | 22.2 | In |
Put | NVS250321P00125000 | 0 | 125.0 | 27.5 - 31.4 | 27.5 | In |
Put | NVS250321P00130000 | 0 | 130.0 | 32.4 - 36.7 | 32.4 | In |
Put | NVS250321P00135000 | 0 | 135.0 | 37.0 - 41.3 | 37.0 | In |
Put | NVS250321P00140000 | 0 | 140.0 | 42.2 - 46.7 | 42.2 | In |
Put | NVS250321P00145000 | 0 | 145.0 | 47.2 - 51.5 | 47.2 | In |
Novartis Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Novartis Market Cap Over Time
Market Cap |
| Timeline |
Novartis Total Stockholder Equity
Total Stockholder Equity |
|
Novartis Corporate Directors
| Ton Buechner | Non-Executive Independent Director | Profile | |
| Frans Houten | Non-Executive Independent Director | Profile | |
| Nancy Andrews | Non-Executive Independent Director | Profile | |
| Elizabeth Doherty | Non-Executive Independent Director | Profile |
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.